Xencor | Dochód Netto



Net Income Zmiana Data
AbbVie USD 1.29B 1.31B 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Amgen USD 1.73B 1.1B 2025-03
Arrowhead Research USD 370.44M 543.53M 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Biogen USD 240.5M 26.2M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
J&J USD 11B 7.57B 2025-03
MacroGenics USD -15421000 71.73M 2024-12
Merck USD 5.08B 1.34B 2025-03
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Roche Holding CHF 1.01B 2.12B 2024-12
Xencor USD -53479000 8.34M 2024-12



Xencor Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.